nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP2D6—Fingolimod—multiple sclerosis	0.0462	0.121	CbGbCtD
Risperidone—ABCB1—Methylprednisolone—multiple sclerosis	0.0316	0.083	CbGbCtD
Risperidone—CYP3A4—Fingolimod—multiple sclerosis	0.0294	0.0772	CbGbCtD
Risperidone—HTR1B—trigeminal nucleus—multiple sclerosis	0.026	0.147	CbGeAlD
Risperidone—HTR1D—trigeminal nucleus—multiple sclerosis	0.0252	0.142	CbGeAlD
Risperidone—CYP3A7—Dexamethasone—multiple sclerosis	0.0245	0.0643	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0245	0.0643	CbGbCtD
Risperidone—ABCB1—Mitoxantrone—multiple sclerosis	0.023	0.0606	CbGbCtD
Risperidone—ABCB1—Betamethasone—multiple sclerosis	0.0205	0.054	CbGbCtD
Risperidone—ABCB1—Prednisolone—multiple sclerosis	0.0203	0.0533	CbGbCtD
Risperidone—ABCB1—Prednisone—multiple sclerosis	0.0191	0.0503	CbGbCtD
Risperidone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0189	0.0498	CbGbCtD
Risperidone—CYP3A5—Dexamethasone—multiple sclerosis	0.0184	0.0483	CbGbCtD
Risperidone—HTR1D—meninx—multiple sclerosis	0.0167	0.0944	CbGeAlD
Risperidone—CYP3A4—Triamcinolone—multiple sclerosis	0.0143	0.0377	CbGbCtD
Risperidone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0138	0.0363	CbGbCtD
Risperidone—HTR2A—trigeminal nucleus—multiple sclerosis	0.0125	0.0706	CbGeAlD
Risperidone—CYP3A4—Betamethasone—multiple sclerosis	0.0123	0.0324	CbGbCtD
Risperidone—CYP3A4—Prednisolone—multiple sclerosis	0.0121	0.0319	CbGbCtD
Risperidone—ABCB1—Dexamethasone—multiple sclerosis	0.0119	0.0314	CbGbCtD
Risperidone—CYP3A4—Prednisone—multiple sclerosis	0.0115	0.0301	CbGbCtD
Risperidone—CYP2D6—Dexamethasone—multiple sclerosis	0.0113	0.0296	CbGbCtD
Risperidone—ABCB1—Methotrexate—multiple sclerosis	0.0096	0.0252	CbGbCtD
Risperidone—CYP3A4—Dexamethasone—multiple sclerosis	0.00716	0.0188	CbGbCtD
Risperidone—HTR1B—trigeminal nerve—multiple sclerosis	0.00684	0.0386	CbGeAlD
Risperidone—HTR1D—trigeminal nerve—multiple sclerosis	0.00662	0.0373	CbGeAlD
Risperidone—HTR7—pons—multiple sclerosis	0.00371	0.0209	CbGeAlD
Risperidone—HTR2A—trigeminal nerve—multiple sclerosis	0.00329	0.0186	CbGeAlD
Risperidone—DRD1—nerve—multiple sclerosis	0.00308	0.0174	CbGeAlD
Risperidone—HTR7—peripheral nervous system—multiple sclerosis	0.00247	0.0139	CbGeAlD
Risperidone—HTR2A—pons—multiple sclerosis	0.00231	0.0131	CbGeAlD
Risperidone—HTR7—nerve—multiple sclerosis	0.00193	0.0109	CbGeAlD
Risperidone—DRD2—nerve—multiple sclerosis	0.00182	0.0103	CbGeAlD
Risperidone—ADRA2A—peripheral nervous system—multiple sclerosis	0.00181	0.0102	CbGeAlD
Risperidone—HTR2A—pineal body—multiple sclerosis	0.00165	0.00933	CbGeAlD
Risperidone—HTR2A—peripheral nervous system—multiple sclerosis	0.00154	0.00869	CbGeAlD
Risperidone—DRD1—brainstem—multiple sclerosis	0.00132	0.00746	CbGeAlD
Risperidone—H1F0—retina—multiple sclerosis	0.00129	0.00729	CbGeAlD
Risperidone—HTR2A—nerve—multiple sclerosis	0.0012	0.00678	CbGeAlD
Risperidone—HTR1B—brainstem—multiple sclerosis	0.00107	0.00605	CbGeAlD
Risperidone—DRD4—brain—multiple sclerosis	0.00105	0.00594	CbGeAlD
Risperidone—HTR1D—brainstem—multiple sclerosis	0.00104	0.00585	CbGeAlD
Risperidone—HTR2C—brainstem—multiple sclerosis	0.00103	0.0058	CbGeAlD
Risperidone—DRD3—nervous system—multiple sclerosis	0.000968	0.00546	CbGeAlD
Risperidone—H1F0—medulla oblongata—multiple sclerosis	0.000934	0.00527	CbGeAlD
Risperidone—DRD3—central nervous system—multiple sclerosis	0.000932	0.00526	CbGeAlD
Risperidone—HTR1A—brainstem—multiple sclerosis	0.000865	0.00488	CbGeAlD
Risperidone—H1F0—midbrain—multiple sclerosis	0.000854	0.00482	CbGeAlD
Risperidone—DRD1—midbrain—multiple sclerosis	0.000843	0.00476	CbGeAlD
Risperidone—H1F0—spinal cord—multiple sclerosis	0.000833	0.0047	CbGeAlD
Risperidone—HTR7—brainstem—multiple sclerosis	0.000826	0.00466	CbGeAlD
Risperidone—ADRA1A—brainstem—multiple sclerosis	0.000797	0.0045	CbGeAlD
Risperidone—DRD2—brainstem—multiple sclerosis	0.000781	0.00441	CbGeAlD
Risperidone—DRD2—retina—multiple sclerosis	0.000754	0.00425	CbGeAlD
Risperidone—ADRA1B—nervous system—multiple sclerosis	0.000743	0.0042	CbGeAlD
Risperidone—DRD3—brain—multiple sclerosis	0.00074	0.00417	CbGeAlD
Risperidone—HTR2C—medulla oblongata—multiple sclerosis	0.000716	0.00404	CbGeAlD
Risperidone—ADRA1B—central nervous system—multiple sclerosis	0.000716	0.00404	CbGeAlD
Risperidone—H1F0—nervous system—multiple sclerosis	0.000702	0.00396	CbGeAlD
Risperidone—DRD1—nervous system—multiple sclerosis	0.000693	0.00391	CbGeAlD
Risperidone—HTR1B—midbrain—multiple sclerosis	0.000683	0.00385	CbGeAlD
Risperidone—H1F0—central nervous system—multiple sclerosis	0.000676	0.00381	CbGeAlD
Risperidone—DRD1—central nervous system—multiple sclerosis	0.000667	0.00376	CbGeAlD
Risperidone—HTR1B—spinal cord—multiple sclerosis	0.000666	0.00376	CbGeAlD
Risperidone—HTR1D—midbrain—multiple sclerosis	0.000661	0.00373	CbGeAlD
Risperidone—H1F0—cerebellum—multiple sclerosis	0.00066	0.00373	CbGeAlD
Risperidone—HTR2C—midbrain—multiple sclerosis	0.000655	0.0037	CbGeAlD
Risperidone—HTR2C—spinal cord—multiple sclerosis	0.000639	0.00361	CbGeAlD
Risperidone—HTR7—medulla oblongata—multiple sclerosis	0.000576	0.00325	CbGeAlD
Risperidone—ADRA1B—brain—multiple sclerosis	0.000568	0.00321	CbGeAlD
Risperidone—HTR1B—nervous system—multiple sclerosis	0.000561	0.00317	CbGeAlD
Risperidone—HTR1A—midbrain—multiple sclerosis	0.000551	0.00311	CbGeAlD
Risperidone—HTR1D—nervous system—multiple sclerosis	0.000544	0.00307	CbGeAlD
Risperidone—HTR1B—central nervous system—multiple sclerosis	0.000541	0.00305	CbGeAlD
Risperidone—HTR2C—nervous system—multiple sclerosis	0.000538	0.00304	CbGeAlD
Risperidone—HTR1A—spinal cord—multiple sclerosis	0.000538	0.00303	CbGeAlD
Risperidone—KCNH2—medulla oblongata—multiple sclerosis	0.000537	0.00303	CbGeAlD
Risperidone—H1F0—brain—multiple sclerosis	0.000536	0.00303	CbGeAlD
Risperidone—ADRA2C—medulla oblongata—multiple sclerosis	0.00053	0.00299	CbGeAlD
Risperidone—DRD1—brain—multiple sclerosis	0.00053	0.00299	CbGeAlD
Risperidone—HTR7—midbrain—multiple sclerosis	0.000527	0.00297	CbGeAlD
Risperidone—HTR1D—central nervous system—multiple sclerosis	0.000523	0.00295	CbGeAlD
Risperidone—HTR2C—central nervous system—multiple sclerosis	0.000518	0.00292	CbGeAlD
Risperidone—HTR2A—brainstem—multiple sclerosis	0.000515	0.00291	CbGeAlD
Risperidone—HTR7—spinal cord—multiple sclerosis	0.000514	0.0029	CbGeAlD
Risperidone—HTR2B—nervous system—multiple sclerosis	0.000506	0.00285	CbGeAlD
Risperidone—DRD2—midbrain—multiple sclerosis	0.000498	0.00281	CbGeAlD
Risperidone—HTR2A—retina—multiple sclerosis	0.000497	0.00281	CbGeAlD
Risperidone—KCNH2—midbrain—multiple sclerosis	0.000491	0.00277	CbGeAlD
Risperidone—HTR2B—central nervous system—multiple sclerosis	0.000487	0.00275	CbGeAlD
Risperidone—ADRA2C—midbrain—multiple sclerosis	0.000484	0.00273	CbGeAlD
Risperidone—KCNH2—spinal cord—multiple sclerosis	0.000479	0.0027	CbGeAlD
Risperidone—ADRA2C—spinal cord—multiple sclerosis	0.000472	0.00267	CbGeAlD
Risperidone—CYP2D6—brainstem—multiple sclerosis	0.000469	0.00265	CbGeAlD
Risperidone—HTR1A—nervous system—multiple sclerosis	0.000453	0.00256	CbGeAlD
Risperidone—HTR1A—central nervous system—multiple sclerosis	0.000436	0.00246	CbGeAlD
Risperidone—HTR7—nervous system—multiple sclerosis	0.000433	0.00244	CbGeAlD
Risperidone—HTR1B—brain—multiple sclerosis	0.000429	0.00242	CbGeAlD
Risperidone—HTR1A—cerebellum—multiple sclerosis	0.000426	0.00241	CbGeAlD
Risperidone—ADRA2A—medulla oblongata—multiple sclerosis	0.000423	0.00239	CbGeAlD
Risperidone—ADRA1A—nervous system—multiple sclerosis	0.000418	0.00236	CbGeAlD
Risperidone—HTR7—central nervous system—multiple sclerosis	0.000417	0.00235	CbGeAlD
Risperidone—HTR1D—brain—multiple sclerosis	0.000415	0.00234	CbGeAlD
Risperidone—HTR2C—brain—multiple sclerosis	0.000411	0.00232	CbGeAlD
Risperidone—DRD2—nervous system—multiple sclerosis	0.000409	0.00231	CbGeAlD
Risperidone—HTR7—cerebellum—multiple sclerosis	0.000407	0.0023	CbGeAlD
Risperidone—KCNH2—nervous system—multiple sclerosis	0.000403	0.00228	CbGeAlD
Risperidone—ADRA1A—central nervous system—multiple sclerosis	0.000402	0.00227	CbGeAlD
Risperidone—ADRA2C—nervous system—multiple sclerosis	0.000398	0.00225	CbGeAlD
Risperidone—DRD2—central nervous system—multiple sclerosis	0.000394	0.00222	CbGeAlD
Risperidone—ADRA1A—cerebellum—multiple sclerosis	0.000393	0.00222	CbGeAlD
Risperidone—KCNH2—central nervous system—multiple sclerosis	0.000388	0.00219	CbGeAlD
Risperidone—HTR2B—brain—multiple sclerosis	0.000386	0.00218	CbGeAlD
Risperidone—ADRA2A—midbrain—multiple sclerosis	0.000386	0.00218	CbGeAlD
Risperidone—DRD2—cerebellum—multiple sclerosis	0.000385	0.00217	CbGeAlD
Risperidone—ADRA2C—central nervous system—multiple sclerosis	0.000383	0.00216	CbGeAlD
Risperidone—KCNH2—cerebellum—multiple sclerosis	0.00038	0.00214	CbGeAlD
Risperidone—ADRA2A—spinal cord—multiple sclerosis	0.000377	0.00213	CbGeAlD
Risperidone—ADRA2C—cerebellum—multiple sclerosis	0.000374	0.00211	CbGeAlD
Risperidone—HTR2A—medulla oblongata—multiple sclerosis	0.000359	0.00203	CbGeAlD
Risperidone—HTR1A—brain—multiple sclerosis	0.000346	0.00195	CbGeAlD
Risperidone—HTR7—brain—multiple sclerosis	0.000331	0.00187	CbGeAlD
Risperidone—HTR2A—midbrain—multiple sclerosis	0.000328	0.00185	CbGeAlD
Risperidone—ABCB1—retina—multiple sclerosis	0.000326	0.00184	CbGeAlD
Risperidone—HRH1—nervous system—multiple sclerosis	0.000323	0.00182	CbGeAlD
Risperidone—HTR2A—spinal cord—multiple sclerosis	0.00032	0.00181	CbGeAlD
Risperidone—ADRA1A—brain—multiple sclerosis	0.000319	0.0018	CbGeAlD
Risperidone—ADRA2A—nervous system—multiple sclerosis	0.000318	0.00179	CbGeAlD
Risperidone—DRD2—brain—multiple sclerosis	0.000313	0.00177	CbGeAlD
Risperidone—HRH1—central nervous system—multiple sclerosis	0.000311	0.00176	CbGeAlD
Risperidone—KCNH2—brain—multiple sclerosis	0.000308	0.00174	CbGeAlD
Risperidone—ADRA2A—central nervous system—multiple sclerosis	0.000306	0.00173	CbGeAlD
Risperidone—ADRA2C—brain—multiple sclerosis	0.000304	0.00172	CbGeAlD
Risperidone—ADRA2A—cerebellum—multiple sclerosis	0.000299	0.00169	CbGeAlD
Risperidone—HTR2A—nervous system—multiple sclerosis	0.00027	0.00152	CbGeAlD
Risperidone—HTR2A—central nervous system—multiple sclerosis	0.00026	0.00147	CbGeAlD
Risperidone—HTR2A—cerebellum—multiple sclerosis	0.000254	0.00143	CbGeAlD
Risperidone—CYP3A4—nervous system—multiple sclerosis	0.00025	0.00141	CbGeAlD
Risperidone—HRH1—brain—multiple sclerosis	0.000247	0.00139	CbGeAlD
Risperidone—CYP2D6—nervous system—multiple sclerosis	0.000246	0.00139	CbGeAlD
Risperidone—ADRA2A—brain—multiple sclerosis	0.000243	0.00137	CbGeAlD
Risperidone—CYP3A4—central nervous system—multiple sclerosis	0.000241	0.00136	CbGeAlD
Risperidone—CYP2D6—central nervous system—multiple sclerosis	0.000237	0.00134	CbGeAlD
Risperidone—ABCB1—medulla oblongata—multiple sclerosis	0.000235	0.00133	CbGeAlD
Risperidone—CYP2D6—cerebellum—multiple sclerosis	0.000231	0.00131	CbGeAlD
Risperidone—ABCB1—midbrain—multiple sclerosis	0.000215	0.00121	CbGeAlD
Risperidone—ABCB1—spinal cord—multiple sclerosis	0.00021	0.00119	CbGeAlD
Risperidone—HTR2A—brain—multiple sclerosis	0.000206	0.00116	CbGeAlD
Risperidone—CYP2D6—brain—multiple sclerosis	0.000188	0.00106	CbGeAlD
Risperidone—ABCB1—nervous system—multiple sclerosis	0.000177	0.000999	CbGeAlD
Risperidone—ABCB1—central nervous system—multiple sclerosis	0.00017	0.000961	CbGeAlD
Risperidone—ABCB1—cerebellum—multiple sclerosis	0.000167	0.00094	CbGeAlD
Risperidone—ABCB1—brain—multiple sclerosis	0.000135	0.000763	CbGeAlD
Risperidone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000111	0.000368	CcSEcCtD
Risperidone—Erythema—Prednisone—multiple sclerosis	0.000111	0.000368	CcSEcCtD
Risperidone—Malnutrition—Prednisone—multiple sclerosis	0.000111	0.000368	CcSEcCtD
Risperidone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000111	0.000367	CcSEcCtD
Risperidone—Agranulocytosis—Methotrexate—multiple sclerosis	0.000111	0.000367	CcSEcCtD
Risperidone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000111	0.000366	CcSEcCtD
Risperidone—Convulsion—Betamethasone—multiple sclerosis	0.000111	0.000366	CcSEcCtD
Risperidone—Convulsion—Dexamethasone—multiple sclerosis	0.000111	0.000366	CcSEcCtD
Risperidone—Hypertension—Betamethasone—multiple sclerosis	0.00011	0.000364	CcSEcCtD
Risperidone—Hypertension—Dexamethasone—multiple sclerosis	0.00011	0.000364	CcSEcCtD
Risperidone—Asthenia—Mitoxantrone—multiple sclerosis	0.000109	0.000361	CcSEcCtD
Risperidone—Myalgia—Dexamethasone—multiple sclerosis	0.000109	0.000359	CcSEcCtD
Risperidone—Myalgia—Betamethasone—multiple sclerosis	0.000109	0.000359	CcSEcCtD
Risperidone—Anxiety—Dexamethasone—multiple sclerosis	0.000108	0.000358	CcSEcCtD
Risperidone—Anxiety—Betamethasone—multiple sclerosis	0.000108	0.000358	CcSEcCtD
Risperidone—Discomfort—Dexamethasone—multiple sclerosis	0.000107	0.000355	CcSEcCtD
Risperidone—Discomfort—Betamethasone—multiple sclerosis	0.000107	0.000355	CcSEcCtD
Risperidone—Haemoglobin—Methotrexate—multiple sclerosis	0.000107	0.000355	CcSEcCtD
Risperidone—Hypotension—Methylprednisolone—multiple sclerosis	0.000107	0.000354	CcSEcCtD
Risperidone—Pain—Prednisolone—multiple sclerosis	0.000107	0.000353	CcSEcCtD
Risperidone—Haemorrhage—Methotrexate—multiple sclerosis	0.000107	0.000353	CcSEcCtD
Risperidone—Hepatitis—Methotrexate—multiple sclerosis	0.000107	0.000353	CcSEcCtD
Risperidone—Pharyngitis—Methotrexate—multiple sclerosis	0.000106	0.00035	CcSEcCtD
Risperidone—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000105	0.000349	CcSEcCtD
Risperidone—Vision blurred—Prednisone—multiple sclerosis	0.000105	0.000346	CcSEcCtD
Risperidone—Urethral disorder—Methotrexate—multiple sclerosis	0.000105	0.000346	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000105	0.000346	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000104	0.000345	CcSEcCtD
Risperidone—Oedema—Dexamethasone—multiple sclerosis	0.000104	0.000344	CcSEcCtD
Risperidone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000104	0.000344	CcSEcCtD
Risperidone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000104	0.000344	CcSEcCtD
Risperidone—Oedema—Betamethasone—multiple sclerosis	0.000104	0.000344	CcSEcCtD
Risperidone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000104	0.000344	CcSEcCtD
Risperidone—Insomnia—Triamcinolone—multiple sclerosis	0.000104	0.000343	CcSEcCtD
Risperidone—Insomnia—Methylprednisolone—multiple sclerosis	0.000104	0.000343	CcSEcCtD
Risperidone—Infection—Betamethasone—multiple sclerosis	0.000103	0.000342	CcSEcCtD
Risperidone—Infection—Dexamethasone—multiple sclerosis	0.000103	0.000342	CcSEcCtD
Risperidone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000103	0.000341	CcSEcCtD
Risperidone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000103	0.000341	CcSEcCtD
Risperidone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000103	0.00034	CcSEcCtD
Risperidone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000103	0.00034	CcSEcCtD
Risperidone—Visual impairment—Methotrexate—multiple sclerosis	0.000103	0.00034	CcSEcCtD
Risperidone—Anaemia—Prednisone—multiple sclerosis	0.000103	0.00034	CcSEcCtD
Risperidone—Shock—Dexamethasone—multiple sclerosis	0.000102	0.000339	CcSEcCtD
Risperidone—Shock—Betamethasone—multiple sclerosis	0.000102	0.000339	CcSEcCtD
Risperidone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000102	0.000338	CcSEcCtD
Risperidone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000102	0.000338	CcSEcCtD
Risperidone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000102	0.000338	CcSEcCtD
Risperidone—Agitation—Prednisone—multiple sclerosis	0.000102	0.000338	CcSEcCtD
Risperidone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000102	0.000337	CcSEcCtD
Risperidone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000102	0.000337	CcSEcCtD
Risperidone—Tachycardia—Dexamethasone—multiple sclerosis	0.000102	0.000336	CcSEcCtD
Risperidone—Tachycardia—Betamethasone—multiple sclerosis	0.000102	0.000336	CcSEcCtD
Risperidone—Angioedema—Prednisone—multiple sclerosis	0.000102	0.000336	CcSEcCtD
Risperidone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000101	0.000334	CcSEcCtD
Risperidone—Erythema multiforme—Methotrexate—multiple sclerosis	0.000101	0.000334	CcSEcCtD
Risperidone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000101	0.000333	CcSEcCtD
Risperidone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000101	0.000333	CcSEcCtD
Risperidone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000101	0.000333	CcSEcCtD
Risperidone—Malaise—Prednisone—multiple sclerosis	0.0001	0.000331	CcSEcCtD
Risperidone—Vertigo—Prednisone—multiple sclerosis	9.99e-05	0.00033	CcSEcCtD
Risperidone—Eye disorder—Methotrexate—multiple sclerosis	9.97e-05	0.00033	CcSEcCtD
Risperidone—Syncope—Prednisone—multiple sclerosis	9.97e-05	0.00033	CcSEcCtD
Risperidone—Tinnitus—Methotrexate—multiple sclerosis	9.95e-05	0.000329	CcSEcCtD
Risperidone—Anorexia—Betamethasone—multiple sclerosis	9.93e-05	0.000328	CcSEcCtD
Risperidone—Anorexia—Dexamethasone—multiple sclerosis	9.93e-05	0.000328	CcSEcCtD
Risperidone—Urticaria—Prednisolone—multiple sclerosis	9.92e-05	0.000328	CcSEcCtD
Risperidone—Cardiac disorder—Methotrexate—multiple sclerosis	9.9e-05	0.000328	CcSEcCtD
Risperidone—Fatigue—Triamcinolone—multiple sclerosis	9.9e-05	0.000327	CcSEcCtD
Risperidone—Fatigue—Methylprednisolone—multiple sclerosis	9.88e-05	0.000327	CcSEcCtD
Risperidone—Pain—Triamcinolone—multiple sclerosis	9.82e-05	0.000325	CcSEcCtD
Risperidone—Loss of consciousness—Prednisone—multiple sclerosis	9.77e-05	0.000323	CcSEcCtD
Risperidone—Hypotension—Dexamethasone—multiple sclerosis	9.73e-05	0.000322	CcSEcCtD
Risperidone—Hypotension—Betamethasone—multiple sclerosis	9.73e-05	0.000322	CcSEcCtD
Risperidone—Angiopathy—Methotrexate—multiple sclerosis	9.68e-05	0.00032	CcSEcCtD
Risperidone—Vomiting—Mitoxantrone—multiple sclerosis	9.67e-05	0.00032	CcSEcCtD
Risperidone—Immune system disorder—Methotrexate—multiple sclerosis	9.64e-05	0.000319	CcSEcCtD
Risperidone—Convulsion—Prednisone—multiple sclerosis	9.63e-05	0.000318	CcSEcCtD
Risperidone—Mediastinal disorder—Methotrexate—multiple sclerosis	9.62e-05	0.000318	CcSEcCtD
Risperidone—Hypertension—Prednisone—multiple sclerosis	9.6e-05	0.000317	CcSEcCtD
Risperidone—Rash—Mitoxantrone—multiple sclerosis	9.59e-05	0.000317	CcSEcCtD
Risperidone—Dermatitis—Mitoxantrone—multiple sclerosis	9.59e-05	0.000317	CcSEcCtD
Risperidone—Chills—Methotrexate—multiple sclerosis	9.57e-05	0.000317	CcSEcCtD
Risperidone—Headache—Mitoxantrone—multiple sclerosis	9.53e-05	0.000315	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.49e-05	0.000314	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.49e-05	0.000314	CcSEcCtD
Risperidone—Myalgia—Prednisone—multiple sclerosis	9.46e-05	0.000313	CcSEcCtD
Risperidone—Arthralgia—Prednisone—multiple sclerosis	9.46e-05	0.000313	CcSEcCtD
Risperidone—Feeling abnormal—Triamcinolone—multiple sclerosis	9.46e-05	0.000313	CcSEcCtD
Risperidone—Feeling abnormal—Methylprednisolone—multiple sclerosis	9.44e-05	0.000312	CcSEcCtD
Risperidone—Anxiety—Prednisone—multiple sclerosis	9.43e-05	0.000312	CcSEcCtD
Risperidone—Alopecia—Methotrexate—multiple sclerosis	9.43e-05	0.000312	CcSEcCtD
Risperidone—Insomnia—Betamethasone—multiple sclerosis	9.42e-05	0.000312	CcSEcCtD
Risperidone—Insomnia—Dexamethasone—multiple sclerosis	9.42e-05	0.000312	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.4e-05	0.000311	CcSEcCtD
Risperidone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.37e-05	0.00031	CcSEcCtD
Risperidone—Paraesthesia—Betamethasone—multiple sclerosis	9.35e-05	0.000309	CcSEcCtD
Risperidone—Paraesthesia—Dexamethasone—multiple sclerosis	9.35e-05	0.000309	CcSEcCtD
Risperidone—Discomfort—Prednisone—multiple sclerosis	9.35e-05	0.000309	CcSEcCtD
Risperidone—Mental disorder—Methotrexate—multiple sclerosis	9.35e-05	0.000309	CcSEcCtD
Risperidone—Erythema—Methotrexate—multiple sclerosis	9.29e-05	0.000307	CcSEcCtD
Risperidone—Malnutrition—Methotrexate—multiple sclerosis	9.29e-05	0.000307	CcSEcCtD
Risperidone—Hypersensitivity—Prednisolone—multiple sclerosis	9.2e-05	0.000304	CcSEcCtD
Risperidone—Dyspepsia—Dexamethasone—multiple sclerosis	9.17e-05	0.000303	CcSEcCtD
Risperidone—Dyspepsia—Betamethasone—multiple sclerosis	9.17e-05	0.000303	CcSEcCtD
Risperidone—Urticaria—Triamcinolone—multiple sclerosis	9.12e-05	0.000302	CcSEcCtD
Risperidone—Urticaria—Methylprednisolone—multiple sclerosis	9.1e-05	0.000301	CcSEcCtD
Risperidone—Dysgeusia—Methotrexate—multiple sclerosis	9.1e-05	0.000301	CcSEcCtD
Risperidone—Body temperature increased—Triamcinolone—multiple sclerosis	9.08e-05	0.0003	CcSEcCtD
Risperidone—Oedema—Prednisone—multiple sclerosis	9.07e-05	0.0003	CcSEcCtD
Risperidone—Anaphylactic shock—Prednisone—multiple sclerosis	9.07e-05	0.0003	CcSEcCtD
Risperidone—Abdominal pain—Methylprednisolone—multiple sclerosis	9.05e-05	0.000299	CcSEcCtD
Risperidone—Decreased appetite—Betamethasone—multiple sclerosis	9.05e-05	0.000299	CcSEcCtD
Risperidone—Decreased appetite—Dexamethasone—multiple sclerosis	9.05e-05	0.000299	CcSEcCtD
Risperidone—Nausea—Mitoxantrone—multiple sclerosis	9.04e-05	0.000299	CcSEcCtD
Risperidone—Infection—Prednisone—multiple sclerosis	9.01e-05	0.000298	CcSEcCtD
Risperidone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	8.99e-05	0.000297	CcSEcCtD
Risperidone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	8.99e-05	0.000297	CcSEcCtD
Risperidone—Back pain—Methotrexate—multiple sclerosis	8.99e-05	0.000297	CcSEcCtD
Risperidone—Fatigue—Dexamethasone—multiple sclerosis	8.98e-05	0.000297	CcSEcCtD
Risperidone—Fatigue—Betamethasone—multiple sclerosis	8.98e-05	0.000297	CcSEcCtD
Risperidone—Shock—Prednisone—multiple sclerosis	8.92e-05	0.000295	CcSEcCtD
Risperidone—Pain—Betamethasone—multiple sclerosis	8.91e-05	0.000295	CcSEcCtD
Risperidone—Pain—Dexamethasone—multiple sclerosis	8.91e-05	0.000295	CcSEcCtD
Risperidone—Nervous system disorder—Prednisone—multiple sclerosis	8.9e-05	0.000294	CcSEcCtD
Risperidone—Tachycardia—Prednisone—multiple sclerosis	8.85e-05	0.000293	CcSEcCtD
Risperidone—Skin disorder—Prednisone—multiple sclerosis	8.81e-05	0.000291	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisone—multiple sclerosis	8.77e-05	0.00029	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—multiple sclerosis	8.75e-05	0.00029	CcSEcCtD
Risperidone—Anorexia—Prednisone—multiple sclerosis	8.65e-05	0.000286	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—multiple sclerosis	8.62e-05	0.000285	CcSEcCtD
Risperidone—Anaemia—Methotrexate—multiple sclerosis	8.59e-05	0.000284	CcSEcCtD
Risperidone—Feeling abnormal—Betamethasone—multiple sclerosis	8.58e-05	0.000284	CcSEcCtD
Risperidone—Feeling abnormal—Dexamethasone—multiple sclerosis	8.58e-05	0.000284	CcSEcCtD
Risperidone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.52e-05	0.000282	CcSEcCtD
Risperidone—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.52e-05	0.000282	CcSEcCtD
Risperidone—Hypersensitivity—Triamcinolone—multiple sclerosis	8.46e-05	0.00028	CcSEcCtD
Risperidone—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.44e-05	0.000279	CcSEcCtD
Risperidone—Malaise—Methotrexate—multiple sclerosis	8.38e-05	0.000277	CcSEcCtD
Risperidone—Vertigo—Methotrexate—multiple sclerosis	8.35e-05	0.000276	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—multiple sclerosis	8.31e-05	0.000275	CcSEcCtD
Risperidone—Urticaria—Dexamethasone—multiple sclerosis	8.27e-05	0.000274	CcSEcCtD
Risperidone—Urticaria—Betamethasone—multiple sclerosis	8.27e-05	0.000274	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.26e-05	0.000273	CcSEcCtD
Risperidone—Dizziness—Prednisolone—multiple sclerosis	8.25e-05	0.000273	CcSEcCtD
Risperidone—Asthenia—Triamcinolone—multiple sclerosis	8.24e-05	0.000272	CcSEcCtD
Risperidone—Body temperature increased—Betamethasone—multiple sclerosis	8.23e-05	0.000272	CcSEcCtD
Risperidone—Body temperature increased—Dexamethasone—multiple sclerosis	8.23e-05	0.000272	CcSEcCtD
Risperidone—Abdominal pain—Betamethasone—multiple sclerosis	8.23e-05	0.000272	CcSEcCtD
Risperidone—Abdominal pain—Dexamethasone—multiple sclerosis	8.23e-05	0.000272	CcSEcCtD
Risperidone—Asthenia—Methylprednisolone—multiple sclerosis	8.22e-05	0.000272	CcSEcCtD
Risperidone—Insomnia—Prednisone—multiple sclerosis	8.2e-05	0.000271	CcSEcCtD
Risperidone—Paraesthesia—Prednisone—multiple sclerosis	8.15e-05	0.000269	CcSEcCtD
Risperidone—Pruritus—Triamcinolone—multiple sclerosis	8.12e-05	0.000269	CcSEcCtD
Risperidone—Cough—Methotrexate—multiple sclerosis	8.11e-05	0.000268	CcSEcCtD
Risperidone—Pruritus—Methylprednisolone—multiple sclerosis	8.1e-05	0.000268	CcSEcCtD
Risperidone—Convulsion—Methotrexate—multiple sclerosis	8.05e-05	0.000266	CcSEcCtD
Risperidone—Dyspepsia—Prednisone—multiple sclerosis	7.99e-05	0.000264	CcSEcCtD
Risperidone—Myalgia—Methotrexate—multiple sclerosis	7.91e-05	0.000262	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—multiple sclerosis	7.91e-05	0.000262	CcSEcCtD
Risperidone—Chest pain—Methotrexate—multiple sclerosis	7.91e-05	0.000262	CcSEcCtD
Risperidone—Decreased appetite—Prednisone—multiple sclerosis	7.89e-05	0.000261	CcSEcCtD
Risperidone—Rash—Prednisolone—multiple sclerosis	7.87e-05	0.00026	CcSEcCtD
Risperidone—Dermatitis—Prednisolone—multiple sclerosis	7.86e-05	0.00026	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	7.85e-05	0.00026	CcSEcCtD
Risperidone—Diarrhoea—Methylprednisolone—multiple sclerosis	7.84e-05	0.000259	CcSEcCtD
Risperidone—Fatigue—Prednisone—multiple sclerosis	7.82e-05	0.000259	CcSEcCtD
Risperidone—Headache—Prednisolone—multiple sclerosis	7.82e-05	0.000259	CcSEcCtD
Risperidone—Discomfort—Methotrexate—multiple sclerosis	7.81e-05	0.000258	CcSEcCtD
Risperidone—Constipation—Prednisone—multiple sclerosis	7.76e-05	0.000257	CcSEcCtD
Risperidone—Confusional state—Methotrexate—multiple sclerosis	7.64e-05	0.000253	CcSEcCtD
Risperidone—Dizziness—Triamcinolone—multiple sclerosis	7.59e-05	0.000251	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—multiple sclerosis	7.58e-05	0.000251	CcSEcCtD
Risperidone—Dizziness—Methylprednisolone—multiple sclerosis	7.57e-05	0.000251	CcSEcCtD
Risperidone—Infection—Methotrexate—multiple sclerosis	7.53e-05	0.000249	CcSEcCtD
Risperidone—Feeling abnormal—Prednisone—multiple sclerosis	7.48e-05	0.000247	CcSEcCtD
Risperidone—Asthenia—Betamethasone—multiple sclerosis	7.47e-05	0.000247	CcSEcCtD
Risperidone—Asthenia—Dexamethasone—multiple sclerosis	7.47e-05	0.000247	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—multiple sclerosis	7.43e-05	0.000246	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—multiple sclerosis	7.42e-05	0.000245	CcSEcCtD
Risperidone—Gastrointestinal pain—Prednisone—multiple sclerosis	7.42e-05	0.000245	CcSEcCtD
Risperidone—Nausea—Prednisolone—multiple sclerosis	7.41e-05	0.000245	CcSEcCtD
Risperidone—Pruritus—Dexamethasone—multiple sclerosis	7.37e-05	0.000244	CcSEcCtD
Risperidone—Pruritus—Betamethasone—multiple sclerosis	7.37e-05	0.000244	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—multiple sclerosis	7.36e-05	0.000244	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—multiple sclerosis	7.33e-05	0.000242	CcSEcCtD
Risperidone—Vomiting—Triamcinolone—multiple sclerosis	7.3e-05	0.000241	CcSEcCtD
Risperidone—Vomiting—Methylprednisolone—multiple sclerosis	7.28e-05	0.000241	CcSEcCtD
Risperidone—Rash—Triamcinolone—multiple sclerosis	7.24e-05	0.000239	CcSEcCtD
Risperidone—Dermatitis—Triamcinolone—multiple sclerosis	7.23e-05	0.000239	CcSEcCtD
Risperidone—Anorexia—Methotrexate—multiple sclerosis	7.23e-05	0.000239	CcSEcCtD
Risperidone—Rash—Methylprednisolone—multiple sclerosis	7.22e-05	0.000239	CcSEcCtD
Risperidone—Dermatitis—Methylprednisolone—multiple sclerosis	7.22e-05	0.000239	CcSEcCtD
Risperidone—Urticaria—Prednisone—multiple sclerosis	7.21e-05	0.000238	CcSEcCtD
Risperidone—Headache—Triamcinolone—multiple sclerosis	7.19e-05	0.000238	CcSEcCtD
Risperidone—Headache—Methylprednisolone—multiple sclerosis	7.18e-05	0.000237	CcSEcCtD
Risperidone—Abdominal pain—Prednisone—multiple sclerosis	7.17e-05	0.000237	CcSEcCtD
Risperidone—Body temperature increased—Prednisone—multiple sclerosis	7.17e-05	0.000237	CcSEcCtD
Risperidone—Diarrhoea—Dexamethasone—multiple sclerosis	7.13e-05	0.000236	CcSEcCtD
Risperidone—Diarrhoea—Betamethasone—multiple sclerosis	7.13e-05	0.000236	CcSEcCtD
Risperidone—Hypotension—Methotrexate—multiple sclerosis	7.08e-05	0.000234	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	6.91e-05	0.000228	CcSEcCtD
Risperidone—Dizziness—Dexamethasone—multiple sclerosis	6.89e-05	0.000228	CcSEcCtD
Risperidone—Dizziness—Betamethasone—multiple sclerosis	6.89e-05	0.000228	CcSEcCtD
Risperidone—Insomnia—Methotrexate—multiple sclerosis	6.86e-05	0.000227	CcSEcCtD
Risperidone—Nausea—Triamcinolone—multiple sclerosis	6.82e-05	0.000226	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—multiple sclerosis	6.81e-05	0.000225	CcSEcCtD
Risperidone—Nausea—Methylprednisolone—multiple sclerosis	6.8e-05	0.000225	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—multiple sclerosis	6.76e-05	0.000224	CcSEcCtD
Risperidone—Somnolence—Methotrexate—multiple sclerosis	6.74e-05	0.000223	CcSEcCtD
Risperidone—Hypersensitivity—Prednisone—multiple sclerosis	6.68e-05	0.000221	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—multiple sclerosis	6.67e-05	0.000221	CcSEcCtD
Risperidone—Vomiting—Dexamethasone—multiple sclerosis	6.62e-05	0.000219	CcSEcCtD
Risperidone—Vomiting—Betamethasone—multiple sclerosis	6.62e-05	0.000219	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—multiple sclerosis	6.59e-05	0.000218	CcSEcCtD
Risperidone—Rash—Dexamethasone—multiple sclerosis	6.57e-05	0.000217	CcSEcCtD
Risperidone—Rash—Betamethasone—multiple sclerosis	6.57e-05	0.000217	CcSEcCtD
Risperidone—Dermatitis—Dexamethasone—multiple sclerosis	6.56e-05	0.000217	CcSEcCtD
Risperidone—Dermatitis—Betamethasone—multiple sclerosis	6.56e-05	0.000217	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.55e-05	0.000216	CcSEcCtD
Risperidone—Fatigue—Methotrexate—multiple sclerosis	6.54e-05	0.000216	CcSEcCtD
Risperidone—Headache—Betamethasone—multiple sclerosis	6.53e-05	0.000216	CcSEcCtD
Risperidone—Headache—Dexamethasone—multiple sclerosis	6.53e-05	0.000216	CcSEcCtD
Risperidone—Asthenia—Prednisone—multiple sclerosis	6.51e-05	0.000215	CcSEcCtD
Risperidone—Pain—Methotrexate—multiple sclerosis	6.48e-05	0.000214	CcSEcCtD
Risperidone—Pruritus—Prednisone—multiple sclerosis	6.42e-05	0.000212	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—multiple sclerosis	6.25e-05	0.000207	CcSEcCtD
Risperidone—Diarrhoea—Prednisone—multiple sclerosis	6.21e-05	0.000205	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.2e-05	0.000205	CcSEcCtD
Risperidone—Nausea—Betamethasone—multiple sclerosis	6.19e-05	0.000205	CcSEcCtD
Risperidone—Nausea—Dexamethasone—multiple sclerosis	6.19e-05	0.000205	CcSEcCtD
Risperidone—Urticaria—Methotrexate—multiple sclerosis	6.02e-05	0.000199	CcSEcCtD
Risperidone—Dizziness—Prednisone—multiple sclerosis	6e-05	0.000198	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—multiple sclerosis	5.99e-05	0.000198	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—multiple sclerosis	5.99e-05	0.000198	CcSEcCtD
Risperidone—Vomiting—Prednisone—multiple sclerosis	5.77e-05	0.000191	CcSEcCtD
Risperidone—Rash—Prednisone—multiple sclerosis	5.72e-05	0.000189	CcSEcCtD
Risperidone—Dermatitis—Prednisone—multiple sclerosis	5.71e-05	0.000189	CcSEcCtD
Risperidone—Headache—Prednisone—multiple sclerosis	5.68e-05	0.000188	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—multiple sclerosis	5.59e-05	0.000185	CcSEcCtD
Risperidone—Asthenia—Methotrexate—multiple sclerosis	5.44e-05	0.00018	CcSEcCtD
Risperidone—Nausea—Prednisone—multiple sclerosis	5.39e-05	0.000178	CcSEcCtD
Risperidone—Pruritus—Methotrexate—multiple sclerosis	5.36e-05	0.000177	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—multiple sclerosis	5.19e-05	0.000172	CcSEcCtD
Risperidone—Dizziness—Methotrexate—multiple sclerosis	5.01e-05	0.000166	CcSEcCtD
Risperidone—Vomiting—Methotrexate—multiple sclerosis	4.82e-05	0.000159	CcSEcCtD
Risperidone—Rash—Methotrexate—multiple sclerosis	4.78e-05	0.000158	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—multiple sclerosis	4.78e-05	0.000158	CcSEcCtD
Risperidone—Headache—Methotrexate—multiple sclerosis	4.75e-05	0.000157	CcSEcCtD
Risperidone—Nausea—Methotrexate—multiple sclerosis	4.5e-05	0.000149	CcSEcCtD
Risperidone—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.06e-05	7.53e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	1.04e-05	7.44e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.04e-05	7.44e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.04e-05	7.43e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—POMC—multiple sclerosis	1.04e-05	7.42e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.04e-05	7.39e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—POMC—multiple sclerosis	1.03e-05	7.39e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.03e-05	7.37e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TYK2—multiple sclerosis	1.03e-05	7.32e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—POMC—multiple sclerosis	1.03e-05	7.32e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCL2—multiple sclerosis	1.02e-05	7.26e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.02e-05	7.25e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.01e-05	7.24e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.01e-05	7.24e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.01e-05	7.19e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1e-05	7.17e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCL2—multiple sclerosis	1e-05	7.16e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	9.98e-06	7.12e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	9.95e-06	7.1e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	9.95e-06	7.1e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	9.91e-06	7.07e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	9.9e-06	7.07e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	9.88e-06	7.05e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCR5—multiple sclerosis	9.86e-06	7.04e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL2—multiple sclerosis	9.82e-06	7.01e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	9.82e-06	7.01e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	9.79e-06	6.99e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—APOE—multiple sclerosis	9.78e-06	6.98e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	9.75e-06	6.96e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	9.74e-06	6.95e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	9.72e-06	6.94e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—ALB—multiple sclerosis	9.71e-06	6.93e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	9.68e-06	6.91e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	9.68e-06	6.91e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	9.67e-06	6.9e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL2—multiple sclerosis	9.64e-06	6.88e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	9.54e-06	6.81e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	9.46e-06	6.76e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—ALB—multiple sclerosis	9.43e-06	6.73e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CD80—multiple sclerosis	9.41e-06	6.72e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CD80—multiple sclerosis	9.36e-06	6.68e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	9.26e-06	6.61e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	9.24e-06	6.6e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TYK2—multiple sclerosis	9.24e-06	6.59e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—APOE—multiple sclerosis	9.14e-06	6.52e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TYK2—multiple sclerosis	9.11e-06	6.51e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	9.1e-06	6.5e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	9.06e-06	6.47e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—APOE—multiple sclerosis	8.99e-06	6.42e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	8.99e-06	6.42e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—APOE—multiple sclerosis	8.97e-06	6.4e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—APOE—multiple sclerosis	8.96e-06	6.4e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	8.96e-06	6.4e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—POMC—multiple sclerosis	8.94e-06	6.38e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL2—multiple sclerosis	8.92e-06	6.37e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—POMC—multiple sclerosis	8.89e-06	6.35e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—IL6—multiple sclerosis	8.87e-06	6.33e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	8.87e-06	6.33e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL2—multiple sclerosis	8.86e-06	6.32e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	8.86e-06	6.32e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	8.82e-06	6.29e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	8.8e-06	6.28e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	8.79e-06	6.28e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	8.75e-06	6.24e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	8.7e-06	6.21e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL2—multiple sclerosis	8.68e-06	6.19e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	8.65e-06	6.18e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	8.63e-06	6.16e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	8.56e-06	6.11e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL2—multiple sclerosis	8.54e-06	6.09e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	8.51e-06	6.08e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	8.51e-06	6.08e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—IL6—multiple sclerosis	8.49e-06	6.06e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	8.46e-06	6.04e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MMP9—multiple sclerosis	8.44e-06	6.03e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—POMC—multiple sclerosis	8.4e-06	6e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	8.39e-06	5.99e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	8.33e-06	5.95e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	8.28e-06	5.91e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CD80—multiple sclerosis	8.26e-06	5.9e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	8.23e-06	5.87e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	8.21e-06	5.86e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	8.18e-06	5.84e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	8.15e-06	5.82e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL2—multiple sclerosis	8.15e-06	5.82e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CD80—multiple sclerosis	8.13e-06	5.8e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CD80—multiple sclerosis	8.11e-06	5.79e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	8.11e-06	5.79e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MMP9—multiple sclerosis	8.08e-06	5.77e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	7.96e-06	5.68e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	7.94e-06	5.67e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	7.9e-06	5.64e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—POMC—multiple sclerosis	7.85e-06	5.6e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—POMC—multiple sclerosis	7.72e-06	5.51e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	7.71e-06	5.51e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—POMC—multiple sclerosis	7.71e-06	5.5e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—POMC—multiple sclerosis	7.7e-06	5.5e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL2—multiple sclerosis	7.69e-06	5.49e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	7.69e-06	5.49e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCL2—multiple sclerosis	7.68e-06	5.48e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—ALB—multiple sclerosis	7.66e-06	5.47e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL6—multiple sclerosis	7.65e-06	5.46e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL2—multiple sclerosis	7.58e-06	5.41e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	7.56e-06	5.4e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	7.56e-06	5.4e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	7.56e-06	5.39e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL6—multiple sclerosis	7.55e-06	5.39e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCL2—multiple sclerosis	7.54e-06	5.38e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	7.51e-06	5.36e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—STAT3—multiple sclerosis	7.51e-06	5.36e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	7.46e-06	5.32e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	7.4e-06	5.28e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	7.4e-06	5.28e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	7.39e-06	5.28e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	7.38e-06	5.27e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	7.3e-06	5.21e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MMP9—multiple sclerosis	7.27e-06	5.19e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	7.24e-06	5.17e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—STAT3—multiple sclerosis	7.18e-06	5.13e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MMP9—multiple sclerosis	7.18e-06	5.12e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	7.03e-06	5.02e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ALB—multiple sclerosis	7.02e-06	5.01e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TYK2—multiple sclerosis	6.97e-06	4.98e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MYC—multiple sclerosis	6.97e-06	4.98e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	6.96e-06	4.97e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MYC—multiple sclerosis	6.93e-06	4.95e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.93e-06	4.94e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	6.91e-06	4.93e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	6.87e-06	4.91e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	6.86e-06	4.9e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	6.86e-06	4.9e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TYK2—multiple sclerosis	6.85e-06	4.89e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	6.85e-06	4.89e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	6.82e-06	4.87e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	6.81e-06	4.86e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MYC—multiple sclerosis	6.78e-06	4.84e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	6.78e-06	4.84e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	6.77e-06	4.83e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—multiple sclerosis	6.76e-06	4.83e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.73e-06	4.8e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	6.72e-06	4.8e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MYC—multiple sclerosis	6.68e-06	4.77e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	6.66e-06	4.75e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	6.64e-06	4.74e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL2—multiple sclerosis	6.61e-06	4.72e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	6.58e-06	4.69e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL2—multiple sclerosis	6.58e-06	4.69e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	6.54e-06	4.67e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	6.53e-06	4.66e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	6.48e-06	4.63e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—STAT3—multiple sclerosis	6.47e-06	4.62e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	6.4e-06	4.57e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—STAT3—multiple sclerosis	6.38e-06	4.56e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—multiple sclerosis	6.37e-06	4.55e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—multiple sclerosis	6.37e-06	4.55e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	6.36e-06	4.54e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	6.36e-06	4.54e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	6.29e-06	4.49e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	6.26e-06	4.47e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	6.26e-06	4.47e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	6.24e-06	4.46e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	6.23e-06	4.45e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	6.22e-06	4.44e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	6.05e-06	4.32e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—multiple sclerosis	6.01e-06	4.29e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	6e-06	4.28e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	5.96e-06	4.25e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—multiple sclerosis	5.93e-06	4.23e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	5.92e-06	4.22e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	5.88e-06	4.2e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—POMC—multiple sclerosis	5.81e-06	4.15e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL2—multiple sclerosis	5.8e-06	4.14e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	5.8e-06	4.14e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—multiple sclerosis	5.77e-06	4.12e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	5.76e-06	4.11e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2—multiple sclerosis	5.71e-06	4.08e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2—multiple sclerosis	5.7e-06	4.07e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	5.68e-06	4.06e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—multiple sclerosis	5.67e-06	4.05e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	5.59e-06	3.99e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	5.56e-06	3.97e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	5.56e-06	3.97e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	5.53e-06	3.95e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—multiple sclerosis	5.49e-06	3.92e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—POMC—multiple sclerosis	5.48e-06	3.91e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	5.4e-06	3.86e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.39e-06	3.85e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	5.38e-06	3.84e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	5.35e-06	3.82e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	5.34e-06	3.81e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ALB—multiple sclerosis	5.3e-06	3.78e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	5.3e-06	3.78e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	5.29e-06	3.78e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—multiple sclerosis	5.24e-06	3.74e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	5.24e-06	3.74e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—multiple sclerosis	5.21e-06	3.72e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	5.19e-06	3.71e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	5.17e-06	3.69e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—multiple sclerosis	5.17e-06	3.69e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	5.16e-06	3.68e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—multiple sclerosis	5.14e-06	3.67e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	5.13e-06	3.66e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—multiple sclerosis	5.1e-06	3.64e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	5.06e-06	3.61e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	5.03e-06	3.59e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—multiple sclerosis	5.02e-06	3.58e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	5e-06	3.57e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ALB—multiple sclerosis	4.99e-06	3.56e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	4.99e-06	3.56e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	4.92e-06	3.51e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	4.92e-06	3.51e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	4.91e-06	3.5e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	4.89e-06	3.49e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—multiple sclerosis	4.88e-06	3.49e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	4.81e-06	3.44e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.8e-06	3.43e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—multiple sclerosis	4.79e-06	3.42e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—multiple sclerosis	4.79e-06	3.42e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	4.7e-06	3.36e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—multiple sclerosis	4.54e-06	3.24e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	4.53e-06	3.23e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—multiple sclerosis	4.52e-06	3.22e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—multiple sclerosis	4.46e-06	3.19e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—multiple sclerosis	4.46e-06	3.18e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.45e-06	3.18e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	4.45e-06	3.18e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.44e-06	3.17e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	4.44e-06	3.17e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	4.37e-06	3.12e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	4.37e-06	3.12e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	4.37e-06	3.12e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	4.36e-06	3.11e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.36e-06	3.11e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	4.28e-06	3.05e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—multiple sclerosis	4.17e-06	2.97e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	4.06e-06	2.9e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	4.05e-06	2.89e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	4.02e-06	2.87e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	3.97e-06	2.84e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.88e-06	2.77e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.86e-06	2.76e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	3.76e-06	2.68e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.7e-06	2.64e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—POMC—multiple sclerosis	3.58e-06	2.56e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—multiple sclerosis	3.41e-06	2.43e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—multiple sclerosis	3.36e-06	2.4e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.35e-06	2.39e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	3.29e-06	2.35e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.26e-06	2.33e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	3.05e-06	2.18e-05	CbGpPWpGaD
